SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-23-045067
Filing Date
2023-06-01
Accepted
2023-06-01 16:35:44
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea179110-f3_altamiratherap.htm F-3 250026
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, SPECIAL BERMUDA COUNSEL TO THE COMPAN ea179110ex5-1_altamira.htm EX-5.1 30484
3 CONSENT OF DELOITTE AG ea179110ex23-2_altamira.htm EX-23.2 4325
4 FILING FEE TABLE ea179110ex-fee_altamira.htm EX-FILING FEES 64692
5 GRAPHIC img_001.jpg GRAPHIC 13896
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4273
  Complete submission text file 0001213900-23-045067.txt   376134
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-272338 | Film No.: 23985248
SIC: 2834 Pharmaceutical Preparations